Cite
APA Citation
Nastoupil, L. J., O'Brien, S., Holmes, H. E., Dsouza, L., Hart, D., Matsuda, E., Satterfield-Ledbetter, T., Skoble, J., Garner, E., Bryan, M., Kanner, S., Li, E., Thomas, C. T., & Essell, J. (n.d.). p1455: FIRST-IN-HUMAN TRIAL OF CB-010, A CRISPR-EDITED ALLOGENEIC ANTI-CD19 CAR -T CELL THERAPY WITH A PD-1 KNOCK OUT, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON-HODGKIN LYMPHOMA (ANTLER STUDY). HemaSphere, 6, 1337–1338. http://access.bl.uk/ark:/81055/vdc_100159756069.0x000003